Showing results (191-200 of 412) with videos related to

Sort By:
Pageof 42
Expert Review of Hematology|February 3, 2015
CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic optionsJorge J Castillo, Julio C Chavez, Francisco J Hernandez-Ilizaliturri, et al.
British Journal of Haematology|October 20, 2025
BCL-2 inhibition in Waldenström macroglobulinaemia and marginal zone lymphomaShayna Sarosiek, Uriel Suarez, Maria Fernandez-Turizo, et al.
Blood|May 31, 2002
Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implicationsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
British Journal of Haematology|November 18, 2020
Partial response or better at six months is prognostic of superior progression-free survival in Waldenström macroglobulinaemia patients treated with ibrutinibJorge J Castillo, Jithma P Abeykoon, Joshua N Gustine, et al.
Leukemia|September 17, 2021
Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemiaJorge J Castillo, Kirsten Meid, Joshua N Gustine, et al.
Blood|June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistanceGuang Yang, Jinhua Wang, Li Tan, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Discovery of a Selective, Covalent IRAK1 Inhibitor with Antiproliferative Activity in MYD88 Mutated B-Cell LymphomaJohn M Hatcher, Guang Yang, Li Wang, et al.
Blood Cancer Journal|July 8, 2026
WNK2 oncogenicity revealed by the discovery and functional characterization of novel gene isoforms in MYD88 mutated Waldenström's MacroglobulinemiaMaria Luisa Guerrera, Xia Liu, Nickolas Tsakmaklis, et al.
Leukemia & Lymphoma|May 26, 2020
Clinicopathologic characteristics and survival of patients with primary effusion lymphomaCristian Aguilar, Caddie Laberiano, Brady Beltran, et al.
American Journal of Hematology|May 15, 2026
Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and ManagementJorge J Castillo, Brady E Beltrán, Jorge A Florindez, et al.
Pageof 42